Chromoendoscopy as an Adjunct to Colonoscopy
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - North Carolina policy alerts
Know when Blue Cross Blue Shield - North Carolina releases new policies or updates existing guidance.
Monitor payer policy activity
This policy addresses the use of dye-based and virtual (electronic) chromoendoscopy as adjuncts to diagnostic or surveillance colonoscopy and defines BCBSNC's coverage stance for providers and members.
No material clinical or coverage changes in this revision.
Coverage Determination
Not covered (investigational)
Policy determination
BCBSNC does not provide coverage for investigational services or procedures.
When Chromoendoscopy as an Adjunct to Colonoscopy is covered: Not applicable. This policy does not list any circumstances in which dye-based or virtual chromoendoscopy used as an adjunct to diagnostic or surveillance colonoscopy is covered.
This policy was originally issued on 07/24/2012, at which time chromoendoscopy and virtual chromoendoscopy were considered investigational when used as adjuncts to diagnostic or surveillance colonoscopy; that investigational stance was documented at initial implementation and carried forward in subsequent updates.
Chromoendoscopy (dye-based) and virtual (electronic/image-enhanced) chromoendoscopy, when used as adjuncts to diagnostic or surveillance colonoscopy, are classified as investigational and therefore not medically necessary under this policy.
Coding and Billing
| 44799 | Unlisted procedure, small intestine (suggested reporting for additional work of chromoendoscopy) |
| No specific code | There is no specific CPT or HCPCS code for chromoendoscopy |
Provider Responsibilities & Billing Notes
No specific code; report additional work with CPT 44799
There is no specific CPT/HCPCS code for chromoendoscopy; the policy states the additional work would probably be reported with unlisted CPT code 44799. Inclusion of a code in the policy does not guarantee reimbursement; see administrative reimbursement policies for details.
- Suggested reporting: unlisted CPT 44799
- Inclusion of a code does not guarantee reimbursement; check BCBSNC administrative policies
Policy is not an authorization; verify benefits/eligibility first
Medical policy is informational only and is not an authorization. Benefits and eligibility must be determined by the member’s group contract/subscriber certificate prior to applying these medical guidelines.
- Medical policy is not an authorization, certification, explanation of benefits, or a contract
- Benefits and eligibility are determined by the group contract and subscriber certificate in effect when services are rendered
If billed, report with 44799 and attach full clinical documentation
Include the suggested unlisted code (44799) and supporting clinical documentation when submitting claims; inclusion of CPT 44799 does not ensure reimbursement and the service remains investigational per policy.
- Suggested reporting: unlisted CPT 44799 for additional chromoendoscopy work
- Service remains investigational and may be denied regardless of coding
Verify benefits/obtain prior authorization from payer as required
Confirm benefits and eligibility with the member’s plan prior to scheduling; because this policy is not an authorization, pre-service determinations should be obtained from the group contract/benefit administrator.
- Medical policy is informational and not a substitute for benefit verification
- Obtain prior authorization or benefit determination from the plan as required by the group contract
Provide complete medical records when requested
When medical records are requested for determination of medical necessity, letters of support or explanation may be useful but are not sufficient unless they include all specific information needed for the medical necessity determination.
- BCBSNC may request medical records to determine medical necessity
- Letters alone are insufficient unless they contain all required clinical details
Expect periodic policy updates and specialty/medical director reviews
This policy has been updated periodically since initial issue (07/24/2012) with regular Specialty Matched Consultant Advisory Panel and Medical Director reviews; providers should expect ongoing policy review and updates.
- Original policy issued 07/24/2012
- Multiple specialty advisory panel and medical director reviews documented through 03/2026
- Policy revisions and reference updates listed in implementation history
Claims for adjunct chromoendoscopy will be denied (investigational)
Claims for chromoendoscopy or virtual chromoendoscopy when used as an adjunct to diagnostic or surveillance colonoscopy will be denied as investigational per this policy.
- Chromoendoscopy and virtual chromoendoscopy are considered investigational as adjuncts to diagnostic or surveillance colonoscopy
- BCBSNC does not provide coverage for investigational services or procedures
Investigational classification established at policy origination (07/24/2012)
This policy initially classified chromoendoscopy and virtual chromoendoscopy as investigational as adjuncts to diagnostic or surveillance colonoscopy when first issued on 07/24/2012; the investigational stance is documented in the policy history.
- New policy issued 07/24/12 stating adjunct chromoendoscopy was investigational
- Subsequent history shows repeated reviews with no change to the policy statement
Background and Rationale
Chromoendoscopy encompasses two approaches: dye-based chromoendoscopy, which applies topical stains or contrast dyes (for example, absorptive stains or indigo carmine) through the endoscope to enhance mucosal visualization, and virtual or image-enhanced chromoendoscopy, which uses endoscope system software (eg, FICE, i-SCAN, narrow band imaging) to digitally modify displayed wavelengths or process images to simulate staining without topical dyes.
The intended purpose of both dye-based and virtual chromoendoscopy is to improve detection and characterization of mucosal abnormalities—particularly flat or subtle lesions—during diagnostic or surveillance colonoscopy. Evidence from randomized trials and meta-analyses shows increased lesion detection in some settings, but studies have limitations and have not demonstrated improved long-term clinical outcomes such as colorectal cancer incidence or mortality.
Definitions
Policy History
Policy documentation and review history — ongoing updates and reviews
Policy updates, guideline changes, and references have been documented at multiple dates with advisory panel and medical director reviews; expect continued maintenance and informational notices rather than automatic authorization changes.
- Recent updates include reviews in 11/2024, 11/2025 and advisory panel review 3/2026
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.